SCHEMBL22322909

SCHEMBL22322909

NC(=O)Cc1ccc(C(=O)N2CCNCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.58
HPGD P15428 2/20 0.54
MKNK1 Q9BUB5 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
GABRD O14764 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48
GABRB2 P47870 1/20 0.48
GABRA4 P48169 1/20 0.48
PARP1 P09874 2/20 0.44
CA2 P00918 1/20 0.44
PARP2 Q9UGN5 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3814817 0.84 HPGD (0.67) HPGDCA2ALDH1A1
SCHEMBL8358137 0.83 SIGMAR1 (0.81) SIGMAR1HPGDMKNK1MKNK2GABRD
SCHEMBL8934917 0.82 SIGMAR1 (0.64) SIGMAR1HPGDMKNK1MKNK2GABRD
SCHEMBL30798838 0.82 SIGMAR1 (0.68) SIGMAR1HPGDMKNK1MKNK2GABRD
SCHEMBL3234988 0.81 HRH3 (0.61) HPGD
SCHEMBL10260239 0.81 SIGMAR1 (0.62) SIGMAR1HPGDMKNK1MKNK2GABRD
Hydrochloric Acid SCHEMBL25324901 0.79 HPGD (0.63) SIGMAR1HPGDMKNK1MKNK2GABRD
SCHEMBL8357615 0.79 SIGMAR1 (0.64) SIGMAR1HPGDMKNK1MKNK2GABRD
SCHEMBL12017808 0.78 GABRD (0.71) SIGMAR1HPGDMKNK1MKNK2GABRD
SCHEMBL1409459 0.78 SIGMAR1 (0.68) SIGMAR1HPGDMKNK1MKNK2GABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3921317-A1 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS Bayer Aktiengesellschaft (DE) 2021-12-15 EP claimed
WO-2020161257-A1 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2020-08-13 WO claimed
EP-4188551-A1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF Bayer Aktiengesellschaft (DE) 2023-06-07 EP disclosed